Registry Cohort Study to Determine Risk for Multiple Sclerosis After Vaccination for Pandemic Influenza A(H1N1) With Arepanrix, Manitoba, Canada

Emerging Infectious Diseases - United States
doi 10.3201/eid2407.161783
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Centers for Disease Control and Prevention (CDC)


Related search